Healthmine Welcomes Maureen Sullivan, Former Chief Strategy and Innovation Officer at Blue Cross Blue Shield Association, to Advisory Board Healthmine, a pioneer in technology-driven member engagement solutions, proudly announces the…
ObjectiveHealth, a leading integrated specialty research network and technology company, announced today that it has secured a strategic growth investment from Vitruvian Partners, a leading global growth-focused investment firm. ObjectiveHealth…
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2023 fourth quarter and year end results for the period…
Current Wellcare President & CEO, Richard Fisher, will join the Operations leadership team under Centene Chief Operating Officer Susan Smith, bringing additional Medicare expertise into Centene’s core services operations Centene Corporation (NYSE: CNC),…
Indianapolis, IN – January 24, 2024 – Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2023 results. “We are pleased to have delivered another year of strong performance…
-The “Automated Blood Tube Labelers and Specimen Transport Boxes – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. Global Automated Blood Tube Labelers and Specimen Transport Boxes Market to Reach $518.8 Million…
Flavia Pease and Timothy Stonesifer to join Board of Directors Shacey Petrovic and Corinne Nevinny to retire from the Board at the Company’s 2024 Annual Meeting -Insulet Corporation (NASDAQ: PODD)…
New partnership expands access among MWI Animal Health’s veterinary practice customers to Hound’s talent management technology a leading provider of state-of-the-art technology solutions and services for veterinary practices, and part…
UnitedHealth Group (NYSE: UNH) reported full year and fourth quarter 2023results reflecting broad-based growth at Optum and UnitedHealthcare.“UnitedHealth Group enters 2024 well prepared to build on our efforts to improve…
today announced several leadership updates, effective immediately: “We are fortunate to have someone of Tom’s caliber and experience already within CVS Health today and ready to take on the role.…
Today CVS Caremark®, a CVS Health® (NYSE: CVS) company, announced the continuation of its efforts to expand adoption of biosimilars. Effective April 1, 2024, Humira® will be removed from our major national…
Elevance Health (NYSE: ELV) today announced that it has entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies. For…